A new strategy for the synthesis of 5H-thiazolo[3,2-a]pyrimidines from KI/K 2 S 2 O 8 mediated CÀ S and CÀ N bond tandem cyclization reaction of enaminones with 3,4-dihydropyrimidin-2(1H)-thiones has been developed. This method features inexpensive catalyst, base free and transition-metal free with simple procedure, affording the desired products in moderate to excellent yields.As one of the most important heterocyclic compounds, thiazolo[3,2-a]pyrimidines not only have been found in wide range of natural products but also have exhibited a wide range of diverse pharmacological activities in medical chemistry, such as anti-inflammatory, antimicrobial, anticancer, antitumor, antibacterial, antiparkinsonian, antinociceptive, and antiviral. [1] In view of their diverse activities, a number of synthetic methods for the synthesis of thiazolo[3,2-a]pyrimidines have been developed over the years. In general, thiazolo[3,2-a]pyrimidine derivatives are synthesized by typical methods including the cyclization of halides such as chloroacetic acid, [2] 2-bromoketones, [3] chloroacetyl chloride, [4] methyl chloroacetate, [5] and 1,2-dichloroethane [6] with 3,4-dihydropyrimidin-2(1H)-thiones. Recently, Singh [7] developed an efficient one-pot method to synthesize thiazolo[3,2-a]pyrimidine derivatives from 3,4-dihydropyrimidin-2(1H)-thiones with in-situ generated bromo-ketones received by reaction of different α-H carbonyl compounds with bromine. Furthermore, copper catalysed CÀ S coupling reaction for the formation of thiazolo[3,2-a]pyrimidine derivatives from 3,4-dihydropyrimidin-2(1H)-thiones with terminal alkynes has also been achieved by Sun group. [8] Later, Karade [9] reported a novel and transition metal-free protocol for the synthesis of thiazolo[3,2-a]pyrimidine derivatives by K 2 CO 3mediated cyclization of 3,4-dihydropyrimidin-2(1H)-thiones with alkynyl(aryl)iodonium tosylates. However, to the best of knowledge, there is no report in describing the synthesis of thiazolo[3,2-a]pyrimidine derivatives involving KI/K 2 S 2 O 8 -mediated CÀ S/CÀ N bond formation of enaminones with 3,4dihydropyrimidin-2(1H)-thiones.